Bass James Edward 4
4 · REATA PHARMACEUTICALS INC · Filed Aug 1, 2017
Insider Transaction Report
Form 4
Bass James Edward
Director
Transactions
- Purchase
Class A common stock
2017-08-01$31.00/sh+8,064$249,984→ 67,411 total
Holdings
- 41,902(indirect: By Trust)
Class A common stock
- 17,555(indirect: By Trust)
Class A common stock
Footnotes (1)
- [F1]Due to the conditions to closing of the public offering of the Class A common stock, these purchases were not deemed to occur until closing, on August 1, 2017.